| | Identification | Back Directory |  | [Name] 
 1-[4-[1-[4-(AMinosulfonyl)phenyl]-3-(trifluoroMethyl)-1H-pyrazol-5-yl]benzoate] β-D-Glucopyranuronic Αcid
 |  | [CAS] 
 264236-79-5
 |  | [Synonyms] 
 Celecoxib metabolite M1
 Celecoxib carboxylic acid glucuronide
 Celecoxib carboxylic acid acyl-b-D-glucuronide
 Celecoxib Carboxylic Acid Acyl-β-D-glucuronide
 Celecoxib Carboxylic Acid Acyl-β-D-Glucuronide
 Celecoxib Carboxylic Acid-Acyl-beta-D-Glucuronide
 Celecoxib carboxylic acid-acyl-beta-D-glucuronide min. 95%
 1-[4-[1-[4-(AMinosulfonyl)phenyl]-3-(trifluoroMethyl)-1H-pyrazol-5-yl]benzoate] β-D-Glucopyranuronic Αcid
 β-D-Glucopyranuronic acid, 1-[4-[1-[4-(aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoate]
 (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-[2-(4-sulfamoylphenyl)-5-(trifluoromethyl)pyrazol-3-yl]benzoyl]oxyoxane-2-carboxylic acid
 |  | [Molecular Formula] 
 C23H20F3N3O10S
 |  | [MDL Number] 
 MFCD28138278
 |  | [MOL File] 
 264236-79-5.mol
 |  | [Molecular Weight] 
 587.48
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 >147°C (dec.)
 |  | [Boiling point ] 
 836.7±75.0 °C(Predicted)
 |  | [density ] 
 1.77±0.1 g/cm3(Predicted)
 |  | [storage temp. ] 
 Hygroscopic, -20°C Freezer, Under inert atmosphere
 |  | [solubility ] 
 Methanol (Slightly, Heated)
 |  | [form ] 
 Solid
 |  | [pka] 
 2.66±0.70(Predicted)
 |  | [color ] 
 Off-White to Pale Yellow
 |  | [Stability:] 
 Hygroscopic
 | 
 | Hazard Information | Back Directory |  | [Description] 
 Celecoxib carboxylic acid acyl-β-D-glucuronide is a phase II metabolite of celecoxib . Celecoxib is an anti-inflammatory compound from the diaryl heterocycle class that selectively inhibits cyclooxygenase-2 (COX-2; IC50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively). Celecoxib carboxylic acid acyl-β-D-glucuronide is a minor metabolite, accounting for 2% of the administered dose in human urine and rat bile.
 |  | [Uses] 
 Celecoxib Carboxylic Acid Acyl-β-D-glucuronide is a glucuronide metabolite of Celecoxib (C251000), a Cox-2 inhibitor.
 |  | [References] 
 [1] S K PAULSON. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.[J]. Drug Metabolism and Disposition, 2000, 28 3: 308-314.
 [2] YONG MA   Ming H  Song Gao. Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles[J]. Journal of Chromatography B, 2015, 1001: Pages 202-211. DOI: 10.1016/j.jchromb.2015.07.026
 [3] Y. AMY SIU . Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C9*3 variants[J]. Drug Metabolism and Pharmacokinetics, 2018, 33 5: Pages 219-227. DOI: 10.1016/j.dmpk.2018.06.001
 | 
 | 
                    
                        
                            | Company Name: | BOC Sciences |  
                            | Tel: | 16314854226 |  
                            | Website: | www.bocsci.com |  |